| Dialysis and Renal Disease Management | Lifetime | 10 | IT 2 | 99.90 |
| Renal and Vascular Pathologies | Lifetime | 16 | IT 2 | 99.70 |
| Blood Pressure and Hypertension Studies | Lifetime | 42 | IT 5 | 99.77 |
| Chronic Kidney Disease and Diabetes | Lifetime | 27 | IT 3 | 99.75 |
| Hemodynamic Monitoring and Therapy | Lifetime | 35 | IT 6 | 99.61 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 162 | IT 5 | 99.46 |
| Parathyroid Disorders and Treatments | Lifetime | 69 | IT 3 | 99.31 |
| Cardiovascular Disease and Adiposity | Lifetime | 149 | IT 5 | 99.15 |
| Cardiovascular Health and Disease Prevention | Lifetime | 157 | IT 10 | 99.09 |
| Ultrasound in Clinical Applications | Lifetime | 71 | IT 3 | 98.65 |
| Nitric Oxide and Endothelin Effects | Lifetime | 223 | IT 8 | 98.94 |
| Cardiovascular Function and Risk Factors | Lifetime | 472 | IT 27 | 99.14 |
| Heart Failure Treatment and Management | Lifetime | 296 | IT 15 | 98.90 |
| Muscle and Compartmental Disorders | Lifetime | 67 | IT 5 | 98.42 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 327 | IT 11 | 98.49 |
| Apelin-related biomedical research | Lifetime | 65 | IT 3 | 97.51 |
| Neurological and metabolic disorders | Lifetime | 88 | IT 2 | 97.73 |
| Potassium and Related Disorders | Lifetime | 86 | IT 3 | 98.02 |
| Heart Rate Variability and Autonomic Control | Lifetime | 682 | IT 54 | 97.90 |
| Sodium Intake and Health | Lifetime | 111 | IT 8 | 98.09 |
| Hormonal Regulation and Hypertension | Lifetime | 548 | IT 30 | 97.62 |
| Renal function and acid-base balance | Lifetime | 250 | IT 10 | 97.27 |
| Central Venous Catheters and Hemodialysis | Lifetime | 386 | IT 19 | 97.30 |
| Electrolyte and hormonal disorders | Lifetime | 349 | IT 9 | 96.73 |
| Folate and B Vitamins Research | Lifetime | 547 | IT 20 | 96.17 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 177 | IT 12 | 96.13 |
| Cardiovascular Issues in Pregnancy | Lifetime | 384 | IT 17 | 96.92 |
| Obstructive Sleep Apnea Research | Lifetime | 492 | IT 22 | 96.97 |
| Renal Diseases and Glomerulopathies | Lifetime | 628 | IT 44 | 97.24 |
| Renin-Angiotensin System Studies | Lifetime | 290 | IT 12 | 97.09 |
| Vitamin D Research Studies | Lifetime | 475 | IT 16 | 96.84 |
| Biomarkers in Disease Mechanisms | Lifetime | 160 | IT 27 | 94.23 |
| Iron Metabolism and Disorders | Lifetime | 866 | IT 53 | 95.64 |
| Healthcare cost, quality, practices | Lifetime | 502 | IT 4 | 94.27 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | Lifetime | 280 | IT 10 | 94.21 |
| Advanced Glycation End Products research | Lifetime | 614 | IT 32 | 93.45 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 710 | IT 58 | 94.29 |
| Organ Donation and Transplantation | Lifetime | 864 | IT 25 | 94.71 |
| Statistical Methods in Clinical Trials | Lifetime | 546 | IT 4 | 94.34 |
| Cardiovascular and Diving-Related Complications | Lifetime | 560 | IT 24 | 93.86 |
| Erythropoietin and Anemia Treatment | Lifetime | 432 | IT 25 | 93.98 |
| Meta-analysis and systematic reviews | Lifetime | 668 | IT 14 | 92.67 |
| Magnesium in Health and Disease | Lifetime | 457 | IT 24 | 90.21 |
| Advanced Causal Inference Techniques | Lifetime | 470 | IT 2 | 90.34 |
| Biomedical Research and Pathophysiology | Lifetime | 995 | IT 46 | 83.03 |
| Heart rate and cardiovascular health | Lifetime | 358 | IT 40 | 81.51 |
| Case Reports on Hematomas | Lifetime | 659 | IT 38 | 73.20 |
| Dialysis and Renal Disease Management | 2021-2025 | 15 | IT 2 | 99.53 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 64 | IT 6 | 98.60 |
| Renal and Vascular Pathologies | 2021-2025 | 27 | IT 9 | 98.39 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 46 | IT 1 | 98.69 |
| Muscle and Compartmental Disorders | 2021-2025 | 8 | IT 2 | 97.26 |
| Hemodynamic Monitoring and Therapy | 2021-2025 | 128 | IT 12 | 95.41 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 915 | IT 32 | 93.32 |
| Electrolyte and hormonal disorders | 2021-2025 | 88 | IT 3 | 91.39 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 556 | IT 48 | 90.46 |
| Sodium Intake and Health | 2021-2025 | 127 | IT 8 | 88.89 |
| Ultrasound in Clinical Applications | 2021-2025 | 294 | IT 53 | 88.59 |
| Heart Failure Treatment and Management | 2021-2025 | 910 | IT 78 | 89.76 |
| Potassium and Related Disorders | 2021-2025 | 134 | IT 11 | 88.95 |
| Central Venous Catheters and Hemodialysis | 2021-2025 | 583 | IT 50 | 81.46 |
| Iron Metabolism and Disorders | 2021-2025 | 764 | IT 49 | 81.93 |
| Hormonal Regulation and Hypertension | 2021-2025 | 916 | IT 74 | 79.61 |
| Acute Kidney Injury Research | 2021-2025 | 814 | IT 41 | 77.02 |
| Neurological and metabolic disorders | 2021-2025 | 192 | IT 14 | 72.52 |
| Health and Medical Research Impacts | 2021-2025 | 659 | IT 6 | 67.91 |
| Advanced Glycation End Products research | 2021-2025 | 802 | IT 33 | 61.87 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 620 | IT 48 | 60.73 |
| Renal function and acid-base balance | 2021-2025 | 532 | IT 26 | 61.88 |
| Heart rate and cardiovascular health | 2021-2025 | 104 | IT 11 | 61.39 |
| Ion Transport and Channel Regulation | 2021-2025 | 581 | IT 35 | 59.26 |
| Neurological Complications and Syndromes | 2021-2025 | 785 | IT 33 | 52.79 |
